LRRK2 and Parkinson disease: A kinase signaling cascade LRRK2→MARKK→MARK might explain enhanced Tau phosphorylation in brains from LRRK2 overexpressing mice and from human PD patients carrying a gain-of-function LRRK2(G2019S) mutation [2].